KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Total Liabilities: 2014-2024

Historic Total Liabilities for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to $2.6 billion.

  • BeOne Medicines' Total Liabilities rose 46.29% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 46.29%. This contributed to the annual value of $2.6 billion for FY2024, which is 14.14% up from last year.
  • Per BeOne Medicines' latest filing, its Total Liabilities stood at $2.6 billion for FY2024, which was up 14.14% from $2.3 billion recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Total Liabilities ranged from a high of $2.6 billion in FY2024 and a low of $1.1 billion during FY2022.
  • Moreover, its 3-year median value for Total Liabilities was $2.3 billion (2023), whereas its average is $2.0 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 173.14% in 2020, then tumbled by 54.31% in 2022.
  • Over the past 5 years, BeOne Medicines' Total Liabilities (Yearly) stood at $1.7 billion in 2020, then soared by 38.78% to $2.4 billion in 2021, then crashed by 54.31% to $1.1 billion in 2022, then surged by 106.59% to $2.3 billion in 2023, then rose by 14.14% to $2.6 billion in 2024.